Tapering and withdrawal of Methotrexate(MTX) or Tocilizumab(TCZ), after achievement of RA remission in concomitant use of MTX and TCZ,a randomized control study.
Phase 4
- Conditions
- rheumatoid arthritis
- Registration Number
- JPRN-UMIN000017577
- Lead Sponsor
- Keio University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients who do not agree to participate in this study 2.Patient with any reasons for inadequate to participate in this study, judged by attending rheumatologist.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method